148 related articles for article (PubMed ID: 32032310)
1. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age.
Newcomer SR; Daley MF; Narwaney KJ; Xu S; DeStefano F; Groom HC; Jackson ML; Lewin BJ; McLean HQ; Nordin JD; Zerbo O; Glanz JM
Pediatr Infect Dis J; 2020 Mar; 39(3):247-253. PubMed ID: 32032310
[TBL] [Abstract][Full Text] [Related]
2. Risk of Nontargeted Infectious Disease Hospitalizations Among US Children Following Inactivated and Live Vaccines, 2005-2014.
Bardenheier BH; McNeil MM; Wodi AP; McNicholl JM; DeStefano F
Clin Infect Dis; 2017 Sep; 65(5):729-737. PubMed ID: 28481979
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
[TBL] [Abstract][Full Text] [Related]
6. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
JAMA; 2014 Feb; 311(8):826-35. PubMed ID: 24570246
[TBL] [Abstract][Full Text] [Related]
7. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
[TBL] [Abstract][Full Text] [Related]
9. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
[No Abstract] [Full Text] [Related]
10. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
Rieckmann A; Hærskjold A; Benn CS; Aaby P; Lange T; Sørup S
Int J Epidemiol; 2019 Dec; 48(6):2026-2038. PubMed ID: 31062020
[TBL] [Abstract][Full Text] [Related]
11. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
12. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
13. Non-specific effects of childhood vaccinations - A case control study nested into a Health and Demographic Surveillance System in rural Burkina Faso.
Pfeiffer G; Fisker AB; Nebié E; Hengelbrock J; Sié A; Becher H; Müller O
Vaccine; 2017 Dec; 35(51):7114-7120. PubMed ID: 29153586
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
17. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
[TBL] [Abstract][Full Text] [Related]
18. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B.
Sun Y; Christensen J; Hviid A; Li J; Vedsted P; Olsen J; Vestergaard M
JAMA; 2012 Feb; 307(8):823-31. PubMed ID: 22357833
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China].
Li H; Zhang XS; An J
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jan; 34(1):24-7. PubMed ID: 23648244
[TBL] [Abstract][Full Text] [Related]
20. Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.
Hechter RC; Qian L; Tartof SY; Sy LS; Klein NP; Weintraub E; Mercado C; Naleway A; McLean HQ; Jacobsen SJ
Vaccine; 2019 May; 37(25):3296-3302. PubMed ID: 31064675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
